Parkinson-kór: vizsgálatok itt: Ausztria
12 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy to Test Effects and Safety of RO7568282 in Early Parkinson's Disease
- Where
- Innsbruck, Linz, Vienna
- Életkor
- 40 év to 85 év
- People
- 474 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07781644 · EU 2025-524064-37-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
- Where
- Graz, Innsbruck, Linz, Vienna
- Életkor
- 50 év to 85 év
- People
- 900 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07174310 · EU 2025-522683-32-00 - 2/3. fázisTaking peopleA Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
- Where
- Innsbruck, Salzburg
- Életkor
- 40 év to 80 év
- People
- 550 worldwide
- Run by
- Biohaven Therapeutics Ltd.
See details and how to joinNCT06976268 · EU 2025-521113-13-00 - 1. fázisTaking peopleA study to test the biological properties of RO7568282 and whether it is safe in healthy participants and participants with Parkinson’s disease.
- Where
- Innsbruck
- Életkor
- 18 év and over
- People
- 150 worldwide
- Run by
- F. Hoffmann-La Roche AG
See details and how to join2024-511110-21-00 · EU 2024-511110-21-00 - No phaseTaking peopleRegistry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
- Where
- Innsbruck
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- Boston Scientific Corporation
See details and how to joinNCT02071134 - No phaseTaking peopleReal-world Patient Experiences With Inbrija®
- Where
- Altmünster, Graz
- Életkor
- 18 év and over
- People
- 120
- Run by
- Merz Therapeutics GmbH
See details and how to joinNCT07797790 - 1. fázisTaking peopleAssessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease
- Where
- Wien
- Életkor
- 40 év to 75 év
- People
- 36 worldwide
- Run by
- Tridem Bioscience FlexCo
See details and how to joinNCT07840027 · EU 2024-519123-14-00 - 1. fázisTaking peopleAn Unblinded, Single Arm, Pilot Observational Study to Test the Safety, Tolerability, Immunogenicity and the Biological Effects of TRB-001 Vaccination.
- Where
- Vienna
- Életkor
- 18 év and over
- People
- 6
- Run by
- Tridem Bioscience FlexCo
See details and how to joinNCT07777484 · EU 2026-526294-42-00 - No phaseTaking peoplePPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
- Where
- Innsbruck
- Életkor
- 30 év and over
- People
- 4500 worldwide
- Run by
- Michael J. Fox Foundation for Parkinson's Research
See details and how to joinNCT04477785 - No phaseTaking peopleObservational Study on "Functional Overlay" in Patients With Movement Disorders
- Where
- Graz
- Életkor
- 18 év to 18 év
- People
- 216
- Run by
- Medical University of Graz
See details and how to joinNCT05943652 - No phaseTaking peopleStudy on Practical ExperienceS of Treatment With Foslevodopa/foScaRbidopa in Advanced Parkinson's Disease
- Where
- Graz
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AbbVie
See details and how to joinNCT06937034 - No phaseTaking peopleSystematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
- Where
- Innsbruck
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Kliniken Beelitz GmbH
See details and how to joinNCT04706234